Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Other financing activities (2016 - 2025)

Dentsply Sirona (XRAY) has disclosed Other financing activities for 15 consecutive years, with -$19.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities fell 216.67% year-over-year to -$19.0 million, compared with a TTM value of -$6.0 million through Dec 2025, up 62.5%, and an annual FY2025 reading of -$6.0 million, up 62.5% over the prior year.
  • Other financing activities was -$19.0 million for Q4 2025 at Dentsply Sirona, down from $16.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $16.0 million in Q3 2025 and bottomed at -$25.0 million in Q4 2021.
  • Average Other financing activities over 5 years is -$5.2 million, with a median of -$4.5 million recorded in 2023.
  • The sharpest move saw Other financing activities skyrocketed 71.43% in 2023, then crashed 400.0% in 2024.
  • Year by year, Other financing activities stood at -$25.0 million in 2021, then soared by 72.0% to -$7.0 million in 2022, then soared by 57.14% to -$3.0 million in 2023, then plummeted by 100.0% to -$6.0 million in 2024, then crashed by 216.67% to -$19.0 million in 2025.
  • Business Quant data shows Other financing activities for XRAY at -$19.0 million in Q4 2025, $16.0 million in Q3 2025, and -$3.0 million in Q1 2025.